Shanghai Shunho: NGP and Industrial Hemp Strategic Layout

Business by 2FIRSTS.ai
May.11.2024
Shanghai Shunho: NGP and Industrial Hemp Strategic Layout
Shanghai Shunho New Materials Technology Co., Ltd. held its 2023 annual performance briefing, focusing on financial reports and business strategies.

On May 10, Shanghai Shunho New Materials Technology Co., Ltd. (stock abbreviation: Shunho Stock, stock code: 002565) held its 2023 annual performance briefing. The briefing was conducted through the Shenzhen Stock Exchange's "Interactive Easy" platform, and included discussions on the company's 2023 financial report, introductions to its new tobacco and industrial hemp businesses, as well as its work in environmental protection and social responsibility.

Shanghai Shunho: NGP and Industrial Hemp Strategic Layout
Shanghai Shunho New Materials Technology Co., Ltd. Investor Relations Activity Record Form | Image Source: Shunho Corporation

 

In response to the adjustment of revenue from the new tobacco business, the company explained that the data in the 2023 interim report has not been audited. During the annual report audit process, in order to more accurately reflect the essence of the new tobacco business, the company will adjust the revenue recognition method from the "gross method" to the "net method," resulting in lower annual revenue compared to the revenue disclosed in the interim report. Shunho Corporation stated that the new tobacco and industrial hemp business are strategically important for the company's business layout, and the company will rigorously and carefully manage the production and operation of these related businesses.

 

In terms of expanding into overseas markets, the company has announced that its investments in Shenzhen Meizhonglian Technology Co., Ltd. and Shenzhen Lvxinfeng Technology Co., Ltd. have obtained relevant licenses. The products they are involved in include disposable e-cigarettes, e-cigarette accessories, pods, heating tobacco products, and others, primarily exporting to countries and regions such as North America, South America, the Middle East, Southeast Asia, the European Union, the United Kingdom, and Japan. 

 

The company has expressed confidence in the future development of the e-cigarette industry, emphasizing that as the inventor and owner of core technology patents, it has been deeply involved in the new tobacco industry for many years and has established a good complementarity and synergy in its domestic and international business layout. As of now, the company's subsidiary, Shenzhen Lvxinfeng Technology Co., Ltd., has obtained the Tobacco Monopoly Production Enterprise License for e-cigarette processing enterprises, while the invested company, Shenzhen Meizhonglian Technology Co., Ltd., has obtained the Tobacco Monopoly Production Enterprise License for e-cigarette product manufacturers. The company's subsidiary, Shanghai Shunho Yilong Electronic Technology Co., Ltd., has obtained the Tobacco Monopoly Production Enterprise License for e-cigarette brand holders for domestic sales.

 

The company can engage in new tobacco business in compliance with relevant regulations in the field, gradually highlighting the company's competitive advantages in production and technology. At the same time, the company is accelerating its overseas layout, rapidly expanding its domestic and international business to form a good situation of complementary advantages in advanced technology research and development applications, resource sharing, and collaborative operations, which has been beneficial for the company and shareholders in exploring and discovering value. In the future, the company will continue to improve the layout of the new tobacco industry chain in production, branding, contract processing, and export at home and abroad, leveraging industry development opportunities, fully leveraging its brand and production processing technology advantages, and striving to secure more market share for the company.

 

In response to investors' questions about profits and research investment, the company stated that they remain optimistic about the development prospects of the biotechnology and health industry, and are closely monitoring the application and development of CBD in areas such as pharmaceuticals, pain management, mental health, health supplements, and daily chemical products.

 

The company stated that it will continue to leverage its technological and production advantages in the fields of new tobacco and industrial hemp, striving to gain more market share as the legalization of industrial hemp rapidly advances in multiple countries around the world. The global market for industrial hemp is further opening up and expanding in industrial applications. As the inventor and owner of core technology patents for new tobacco products, the company established itself early in the industry with strong technological and production advantages. In the future, the company will continuously improve its layout in the domestic and international production, branding, contract manufacturing, and export industries of new tobacco, seizing opportunities for industrial development to fully utilize its brand and production processing technology advantages, and work hard to gain more market share for the company.

 

Regarding ESG ratings, the company stated that it has always placed high importance on environmental protection and social responsibility. It has released a "Social Responsibility Report" for 11 consecutive years and has pledged to continue to focus on and enhance environmental protection and information disclosure efforts.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Product | Republic Technologies Launches ZIG Nicotine Pouches, Expanding Beyond Traditional Tobacco Accessories
Product | Republic Technologies Launches ZIG Nicotine Pouches, Expanding Beyond Traditional Tobacco Accessories
Republic Technologies UK has entered the nicotine pouch market with ZIG Nicotine Pouches, marking the company’s expansion beyond traditional tobacco-related accessories into smoke-free nicotine products. The product is expected to enter UK retail channels from August 2026, including convenience stores, supermarkets and tobacco retailers. The launch includes six flavors and three nicotine strengths: 8mg, 12mg and 17mg.
Market
Jul.21 by 2Firsts Perspectives
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
China’s vape-related exports reached $1.047 billion in July 2026, up 16.5% year on year and the highest monthly total of the year. Growth was heavily concentrated in the U.S., where exports jumped 53.5% to $404 million and accounted for 94.9% of the overall increase. Exports to all other markets rose just 1.2%. By category, nicotine-containing non-combustible products—primarily vapes—under HS24041200 rose 24.7% and generated 95.5% of the total increase. Vape-device exports under HS85434000 fell 0.4%, while other nicotine-substitute products under HS24041990 grew 88.9% but remained comparatively small.
DATA
Aug.24
 $20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
$20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
An Illinois court ordered three companies tied to Posh vapes to pay $20 million and permanently restricted the sale, marketing and distribution in Illinois of products lacking required FDA authorization. The consent order also imposes downstream distributor controls, age-verification measures and social-media marketing limits, creating a new state-level compliance benchmark for disposable vape businesses.
Regulations
Aug.05
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
JTI Korea launched the Ploom AURA Teal Electric Pop limited edition in South Korea on September 1, 2026, marking the first dual-color design in the Ploom AURA range. The device combines a dark green body with teal accents and is accompanied by matching Front Panel, Back Cover and Pocket Bag accessories. The standalone device is priced at KRW 29,000, with three additional device-and-accessory bundles available. The release continues JTI Korea's use of limited colorways and interchangeable accessories to expand the Ploom AURA portfolio without introducing a new hardware platform.
Sep.03